Home > Research > Researchers > Hailay Gesesew

Dr Hailay Gesesew

Honorary Researcher

Hailay Gesesew

Faculty Of Health And Medicine

LA14YX

Lancaster

Profile

I am an Associate Professor of Epidemiology and Principal Research Fellow (Australia's NHMRC), and my research expertise are mainly HIV care continuum and Conflict & health. I am currently leading NHMRC funded project investigating the impact of HIV peer counsellors on HIV care and treatment cascades in Ethiopia (2020-2024). I am a mixed methods reader by design.  

Current Research

Current and recent projects include:

  • Impact of Peer-led HIV-self testing on the HIV care continuum in Ethiopia: A cluster randomized trial and economic evaluation of Teach-Test-Link-Trace model trial (2020-24, funded by NHMRC (Australia))
  • Social and emotional wellbeing of Culturally and Linguistically Diverse (CALD) children and young people in South Australia (2024-25, funded by The Hospital Research Foundation Group (Australia))
  • Conflict-related vicarious trauma among Tigrayan Australian (2023-24, funded by Torrens University Australia)
  • Health Needs Assessment of Culturally and Linguistically Diverse (CALD) population (2023-2024, funded by Primary Health Network Adelaide)
  • I also co-supervise 9 PhD students whose PhD research are around conflict and/or HIV care, contemporary and alternative medicine, universal health coverage, frailty, and mental wellbeing among youths.

Research Interests

I am interested to examine the HIV care continuum in low- and middle-income countries, the impact of conflict on health and perilous medicine in Africa, and social determinants of health. Given my honorary affiliation with an Ethiopian research institute and a University, I am happy to collaborate in NIHR funded projects targeting in low- and middle-income projects.

External PhD Supervision

I am interested in supervising students in the areas of HIV/TB care and conflict & health, with a particular interest in primary care, and models of community-based testing and treatment distribution.

View all (1) »